HOME >> BIOLOGY >> NEWS
Novel gene therapy on the horizon, says Brenner Children's Hospital pediatrician

WINSTON-SALEM, N.C. Researchers at Brenner Children's Hospital are working on a novel gene therapy to help new moms and their babies who suffer from genetic defects, according to findings reported at the Society of Pediatric Research in Seattle today.

R. Mark Payne, M.D., a pediatric cardiologist and researcher at Brenner Children's Hospital, has discovered a new way to transmit proteins across cell membranes a finding that in the future might prevent or treat diseases like Sudden Infant Death Syndrome (SIDS) and Trifunctional Protein (TFP) deficiency in infants and their mothers.

"The treatment involves getting the right protein into the cells or mitochondria they need to function properly," Payne said. "Mitochondria produce most of the energy within cells and defects in their function are among the most common genetic defects in the United States and currently can not be prevented."

Some genetic defects occur when mitochondria lack a certain protein, which cause babies, and in some cases their mothers, to become sick and die, Payne said. Current gene therapy attempts have tried injecting the patient with a virus that corrects the defect. However, the effectiveness of this approach is very poor and the side effects aren't good patients may die from the treatments, according to Payne.

"Instead of injecting a virus into the cells, we want to take the needed protein and inject only that protein into the cells," Payne said. "This is highly efficient technology the needed proteins get absorbed and are positioned correctly within the mitochondria located in the cell, which is necessary to correct the defect."

Payne and his colleagues say this new technology could mean that mothers suffering from genetic abnormalities such as TFP may be able to receive injections until their due date preventing premature delivery and sometimes death for both the mother and infant.

TFP is one of many genetic defects that involve mitochondria
'"/>

Contact: Rae Beasley
rabeasle@wfubmc.edu
336-716-6878
Wake Forest University Baptist Medical Center
4-May-2003


Page: 1 2

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel flu vaccine shows promise in mice
11. Novel method identifies hidden genes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... ... February 28, 2020 , ... ... initial biologics orders. This includes all available stem cell and exosome biologics. , ... umbilical tissue, Exosome Biologics, PRP kits, adipose kits, PDO thread lifts and more. ...
(Date:2/13/2020)... ... ... Murrieta Genomics , the provider of genomics services and a launch ... February 25th from 11:30 am to 1 pm at the University of California Riverside ... to attend this free event, but must register in advance . , “This ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... sciences companies and government agencies, announced the recent appointment of Jonathan Horn ... Tunnell, with significant experience assessing, designing, and managing enterprise transformation initiatives, especially ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... ... 11, 2020 , ... Synagro Technologies, Inc. , the ... that the City of Fort Worth has partnered with Synagro of Texas-CDR (Synagro) ... of 2020, Synagro will assume operation of the city’s current biosolids management facility ...
(Date:2/5/2020)... ... February 04, 2020 , ... Shoreline Biome , ... the strain level, has announced a new distribution partnership in Asia. , The ... products to companies and research organizations in China, Hong Kong, and Macau. , ...
(Date:2/3/2020)... ... February 03, 2020 , ... ... Firm Travel, Law Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. ... Each Index illustrates the following statistics:, Average airfare ...
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle Biotechnologies ... food and beverage manufactures within North America. Both Lifecycle and Midland have supported ... allow each company to pool their collective resources and provide the industry with ...
Breaking Biology Technology:
Cached News: